RAPID AND SUSTAINED IMPROVEMENTS IN BOTH SKIN AND MUSCULOSKELETAL SYMPTOMS CORRELATES WITH IMPROVED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kavanaugh, A. F. [1 ]
Birt, J. [2 ]
Lin, C. -Y. [2 ]
Benichou, O. [3 ]
Hufford, M. [2 ]
Gottlieb, A. B. [4 ]
机构：
[1] Univ CA San Diego Hlth Syst, La Jolla, CA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Paris, France
[4] New York Med Coll, New York, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2331
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0316
引用
收藏
页码：1022 / 1022
页数：1
相关论文
共 50 条
  • [41] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: Long-Term (4-Year) Data from a Phase 3 Study
    McInnes, Iain B.
    Kivitz, Alan J.
    Nash, Peter
    Rahman, Proton
    Rech, Juergen
    Kirkham, Bruce
    Navarra, Sandra V.
    Ding, Kevin
    Ilsley, Emma
    Pricop, Luminita
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: LONG-TERM (4-YEAR) DATA FROM A PHASE 3 STUDY
    McInnes, Iain B.
    Kivitz, Alan J.
    Nash, Peter
    Rahman, Proton
    Rech, Jurgen
    Kirkham, Bruce
    Navarra, Sandra
    Ding, Kevin
    Ilsley, Emma
    Pricop, Luminita
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S5 - S5
  • [43] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
    Hall, S.
    Mease, P.
    Kavanaugh, A.
    Reimold, A.
    Tahir, H.
    Rech, J.
    Geusens, P.
    Pascale, P.
    Delicha, E.
    Pricop, L.
    Mpofu, S.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 37 - 38
  • [44] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2
    Curtis, J.
    Mcinnes, I.
    Rahman, P.
    Gladman, D. D.
    Yang, F.
    Peterson, S.
    Kollmeier, A.
    Shiff, N.
    Han, C.
    Shawi, M.
    Tillett, W.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1568 - 1569
  • [45] Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
    Curtis, Jeffrey
    McInne, Iain B.
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steve
    Kollmeier, Alexa
    Shiff, Natalie
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1014 - 1016
  • [46] Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
    Taylor, Peter C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Young, Pamela
    Germino, Rebecca
    Merola, Joseph F.
    Yosipovitch, Gil
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2614 - 2620
  • [47] Filgotinib Provided Rapid and Sustained Improvements in Functional Status, Pain, Health-related Quality of Life, and Fatigue in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Kivitz, Alan
    Tanaka, Yoshiya
    Lee, Susan
    Ye, Lei
    Hu, Hao
    Besuyen, Robin
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [48] Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two Year Results from a Phase 3 Trial
    Helliwell, Philip S.
    Lespessailles, Eric
    Shuler, Catherine
    Mallbris, Lotus
    Erickson, Janelle
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] IXEKIZUMAB PROVIDES SUSTAINED IMPROVEMENT IN SIGNS AND SYMPTOMS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: TWO YEAR RESULTS FROM A PHASE 3 TRIAL
    Helliwell, P.
    Lespessailles, E.
    Shuler, C. L.
    Mallbris, L.
    Erickson, J.
    Fleischmann, R.
    Moyano, Sebastian
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S159 - S159
  • [50] Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity
    Coates L.C.
    Orbai A.-M.
    Morita A.
    Benichou O.
    Kerr L.
    Adams D.H.
    Shuler C.L.
    Birt J.
    Helliwell P.S.
    BMC Rheumatology, 2 (1)
12345